Lecroy (LCRY) Guides Q2 Sales, EPS; Announces 5M Share Buyback Plan
Tweet
Share
E-mailGet Alerts LCRY Hot Sheet
Price: $14.31 --0%
Financial Fact:
Cost of revenues: 20.16M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Cost of revenues: 20.16M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Lecroy (Nasdaq: LCRY) sees Q2 sales of $51.1 million, which compares to the Street estimate of $50.32 million. Sees EPS of about 30 cents, inline with the Street.
Authorizes a 5 million share buyback program.
Authorizes a 5 million share buyback program.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Reitar Logtech launches $3M share repurchase program
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
- Cosmos Health posts 29% revenue rise in Q2 but net loss widens
Create E-mail Alert Related Categories
Guidance, Stock BuybacksRelated Entities
Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
